Sep 7, 2023 8:00 am EDT Investor Call to Share Topline Results from the Phase 3 RESPONSE Trial of Seladelpar in Primary Biliary Cholangitis
Nov 15, 2021 4:30 pm EDT Post-AASLD Key Opinion Leader Webinar on Seladelpar for Primary Biliary Cholangitis
Aug 27 – Aug 29, 2020 Digital International Liver Congress™ 2020 of the European Association for the Study of Liver (EASL)